Pancreatic Adenocarcinoma — Trials

Pancreatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

914 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 356
Recruiting: 210
Ph III recruiting: 23
Growth YoY: +41.4%
Industry share: 41%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 1–50 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07831330	Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer	not yet recruiting	Phase 2	59	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	0	Sep 21, 2026	clinicaltrials
NCT07827053	Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion Therapy in Locally Advanced Pancreatic Cancer	not yet recruiting	Phase 2	36	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine